A mechanism‐based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID‐19 treatment in humans by Patrick O. Hanafin, Brian Jermain, Anthony J. Hickey, Alexander V. Kabanov, Angela DM. Kashuba, Timothy P. Sheahan, Gauri G. Rao

Connect to this object online.

Proof‐of‐concept for incorporating mechanistic insights from multi‐omics analyses of polymyxin B in combination with chloramphenicol against Klebsiella pneumoniae by Patrick O. Hanafin, Nusaibah Abdul Rahim, Rajnikant Sharma, Colin G. Cess, Stacey D. Finley, Phillip J. Bergen, Tony Velkov, Jian Li, Gauri G. Rao

Connect to this object online.

Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis by Patrick O. Hanafin, Isabelle Sermet-Gaudelus, Matthias Griese, Matthias Kappler, Helmut Ellemunter, Carsten Schwarz, Carsten Schwarz, John Wilson, John Wilson, Marsha Tan, Tony Velkov, Gauri G. Rao, Elena K. Schneider-Futschik

Connect to this object online.

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients by Patrick O. Hanafin, Roger L. Nation, Marc H. Scheetz, Alexandre P. Zavascki, Ana M. Sandri, Andrea L. Kwa, Benjamin P. Z. Cherng, Christine J. Kubin, Michael T. Yin, Jiping Wang, Jian Li, Keith S. Kaye, Gauri G. Rao

Connect to this object online.